Forward Pharma FA ApS: Financial statements 2017
CVR: 37281603
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Forward Pharma FA ApS (CVR 37281603) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -568,692 and a net result of DKK -447,221 compared with DKK -1,713,436 the year before. Equity in the 2017 report amounted to DKK -28,632.
- Gross Profit
- DKK -568,692
- Profit/Loss
- DKK -447,221
- Equity
- DKK -28,632
- Total Assets
- DKK 781,520
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -569 t. | -447 t. | -29 t. | - |
| 2016 | - | -2.2 mio. | -1.7 mio. | 419 t. | - |
Keep an eye on Forward Pharma FA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Forward Pharma FA ApS has published its annual report for 2016. Gross profit came to DKK -2,245,551, and the net result was DKK -1,713,436.
As of May 31, 2017, Claus Bo Søndergaard Svendsen has joined the board of directors of Forward Pharma FA ApS.
As of May 31, 2017, Claus Bo Søndergaard Svendsen is registered as director of Forward Pharma FA ApS.
As of May 31, 2017, Peder Møller Andersen has stepped down as adm. dir. of Forward Pharma FA ApS.
About Forward Pharma FA ApS
Forward Pharma FA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity in the 2022 report amounted to DKK 39,283.